313 related articles for article (PubMed ID: 10890743)
21. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S
Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775
[TBL] [Abstract][Full Text] [Related]
22. Complementation of a human adenovirus early region 4 deletion mutant in 293 cells using adenovirus-polylysine-DNA complexes.
Scaria A; Curiel DT; Kay MA
Gene Ther; 1995 Jun; 2(4):295-8. PubMed ID: 7552990
[TBL] [Abstract][Full Text] [Related]
23. Influence of E1-deleted recombinant adenoviruses on B7.1 and IL-2 expression in C1498 cells.
Hejazi MS; Sioofy Khojine AB
Iran Biomed J; 2007 Jul; 11(3):153-160. PubMed ID: 18051775
[TBL] [Abstract][Full Text] [Related]
24. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy.
Amalfitano A; Chamberlain JS
Gene Ther; 1997 Mar; 4(3):258-63. PubMed ID: 9135740
[TBL] [Abstract][Full Text] [Related]
26. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors.
Mizuguchi H; Kay MA
Hum Gene Ther; 1999 Aug; 10(12):2013-7. PubMed ID: 10466635
[TBL] [Abstract][Full Text] [Related]
27. Trans complementation of an E1A-deleted adenovirus with codelivered E1A sequences to make recombinant adenoviral producer cells.
Goldsmith KT; Curiel DT; Engler JA; Garver RI
Hum Gene Ther; 1994 Nov; 5(11):1341-8. PubMed ID: 7893805
[TBL] [Abstract][Full Text] [Related]
28. Establishment and validation of new complementing cells for production of E1-deleted adenovirus vectors in serum-free suspension culture.
Gilbert R; Guilbault C; Gagnon D; Bernier A; Bourget L; Elahi SM; Kamen A; Massie B
J Virol Methods; 2014 Nov; 208():177-88. PubMed ID: 25159033
[TBL] [Abstract][Full Text] [Related]
29. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses.
Imler JL; Bout A; Dreyer D; Dieterlé A; Schultz H; Valerio D; Mehtali M; Pavirani A
Hum Gene Ther; 1995 Jun; 6(6):711-21. PubMed ID: 7548271
[TBL] [Abstract][Full Text] [Related]
30. Production of helper-dependent adenovirus vector relies on helper virus structure and complementing.
Zhou HS; Zhao T; Rao XM; Beaudet AL
J Gene Med; 2002; 4(5):498-509. PubMed ID: 12221643
[TBL] [Abstract][Full Text] [Related]
31. A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles.
Von Seggern DJ; Chiu CY; Fleck SK; Stewart PL; Nemerow GR
J Virol; 1999 Feb; 73(2):1601-8. PubMed ID: 9882366
[TBL] [Abstract][Full Text] [Related]
32. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.
Lieber A; He CY; Kirillova I; Kay MA
J Virol; 1996 Dec; 70(12):8944-60. PubMed ID: 8971024
[TBL] [Abstract][Full Text] [Related]
33. A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors.
Zhou H; Beaudet AL
Virology; 2000 Sep; 275(2):348-57. PubMed ID: 10998335
[TBL] [Abstract][Full Text] [Related]
34. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
35. Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production.
Schiedner G; Hertel S; Kochanek S
Hum Gene Ther; 2000 Oct; 11(15):2105-16. PubMed ID: 11044912
[TBL] [Abstract][Full Text] [Related]
36. Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation.
Kojima H; Ohishi N; Yagi K
Biochem Biophys Res Commun; 1998 May; 246(3):868-72. PubMed ID: 9618304
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
Hehir KM; Armentano D; Cardoza LM; Choquette TL; Berthelette PB; White GA; Couture LA; Everton MB; Keegan J; Martin JM; Pratt DA; Smith MP; Smith AE; Wadsworth SC
J Virol; 1996 Dec; 70(12):8459-67. PubMed ID: 8970968
[TBL] [Abstract][Full Text] [Related]
38. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.
Fallaux FJ; Kranenburg O; Cramer SJ; Houweling A; Van Ormondt H; Hoeben RC; Van Der Eb AJ
Hum Gene Ther; 1996 Jan; 7(2):215-22. PubMed ID: 8788172
[TBL] [Abstract][Full Text] [Related]
39. Gene expression changes induced by a recombinant E1-/E3- adenovirus type 5 vector in human mammary epithelial cells.
Scibetta AG; Copier J; Barrett A; Chaplin T; Taylor-Papadimitriou J
Intervirology; 2005; 48(6):350-61. PubMed ID: 16024939
[TBL] [Abstract][Full Text] [Related]
40. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
